Latest Organic chemistry Stories
Kaiser Permanente study first to use electronic health records to document link between prescription opioid use and ED prescriptions PORTLAND, Ore., May 15, 2013 /PRNewswire/ -- Regularly taking prescription painkillers, also known as opioids, is associated with a higher risk of erectile dysfunction, according to a study published online today in the journal Spine. The researchers included more than 11,000 men with back pain in the study and examined their health records to...
WAYNE, N.J., May 15, 2013 /PRNewswire/ -- Bayer HealthCare announced today that patient enrollment is underway for RESORCE (Regorafenib after Sorafenib in Patients with Hepatocellular Carcinoma), an international Phase III trial to evaluate the efficacy and safety of Stivarga(®) (regorafenib) tablets for the treatment of patients with hepatocellular carcinoma (HCC) who have progressed on Nexavar(®) (sorafenib) tablets, an anticancer medicine for the treatment of patients with...
Emergency room visits attributed to sleep aids have increased nearly 220% in recent years, and treatment providers are trying to find solutions to address this growing problem. Malibu, CA (PRWEB) May 14, 2013 According to a recent article in USA Today, the number of emergency room visits attributed to sleep-inducing drugs (particularly Zolpidem, the active ingredient in Ambien) has risen drastically in both numerical scope and severity. According to a report by the Substance Abuse and...
Aegis' Intravail® formulation of sumatriptan achieves therapeutic drug levels in approximately 2 to 3 minutes SAN DIEGO, May 14, 2013 /PRNewswire-iReach/ -- Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 8,440,631, its second patent providing fast acting formulations for triptans, a class of drugs that are effective in treating migraine headaches which include sumatriptan, zolmitriptan, naratriptan, rizatriptan, eletriptan, almotriptan and...
Pradaxa manufacturer also granted more time to produce documents. Resource4thePeople national network of lawyers says there is still time for consumers who may have suffered alleged internal bleeding problems from use of Pradaxa to seek free legal consultations. San Diego, CA (PRWEB) May 12, 2013 http://www.resource4thepeople.com/defectivedrugs/pradaxa-lawsuits.html Resource4thePeople announced today its latest consumer update involving federal court lawsuits involving allegations that...
The firm is currently offering Lipitor lawsuit evaluations to women who have suffered from allegedly serious Lipitor side effects. (PRWEB) May 13, 2013 The popular statin Lipitor has been the focus of a number of research studies, some of which have found a possible link between the drug and an increased risk of type 2 diabetes in women who use Lipitor to help lower their cholesterol levels, according to Reuters.* The Rottenstein Law Group LLP, a Lipitor law firm, offers its opinion on...
The firm is currently offering Pradaxa lawsuit evaluations to those who have suffered from allegedly serious Pradaxa side effects. (PRWEB) May 13, 2013 A major medical journal published a study this month that reported an alleged increase in deaths in patients with closed head injuries who use the blood thinner Pradaxa.* The Pradaxa attorneys at the Rottenstein Law Group LLP acknowledge the study’s results, noting that excessive bleeding is among the drug’s alleged side effects the...
ATLANTA, May 13, 2013 /PRNewswire/ -- Arbor Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Nymalize(TM) (nimodipine) oral solution. Nymalize was previously granted Orphan designation which provides seven years of market exclusivity. Nymalize is the first and only nimodipine oral solution indicated for the improvement of neurological outcome in adult patients with subarachnoid hemorrhage (SAH). Prior to...
SAN DIEGO and IRVINE, Calif., May 13, 2013 /PRNewswire/ -- Sorrento Therapeutics, Inc. ("STI"; SRNE) and IGDRASOL announced today the acquisition of exclusive distribution rights from Samyang Biopharmaceuticals ("Samyang"), a South Korean corporation, to Cynviloq(TM) (marketed as Genexol-PM® in South Korea) in the 27 countries of European Union (EU). IGDRASOL had previously obtained the exclusive U.S. distribution rights to Cynviloq(TM) from Samyang, and with this agreement,...
MALVERN, Pa., May 10, 2013 /PRNewswire/ -- Endo Health Solutions Inc. (Nasdaq: ENDP) announced today that the U.S. Food and Drug Administration (FDA) has denied a Citizen Petition filed by its subsidiary, Endo Pharmaceuticals Inc. Endo presented FDA data collected from an ongoing epidemiology study that indicate that per 100,000 prescriptions dispensed, the past 30-day abuse rate of crush-resistant OPANA ER was 79 percent lower than the abuse rate of generic versions of...
Latest Organic chemistry Reference Libraries
Organometallics is a peer-reviewed scientific journal published by the American Chemical Society. As of May 2012, the editor-in-chief is John A. Gladysz. Organometallics publishes records in one of the most active fields for organometallic, inorganic, organic, and materials chemists. Articles, communications, mini-reviews, and notes detail the synthesis, structure, bonding, chemical reactivity and reaction mechanisms, and applications of organometallic and organometalloidal compounds....
Synthetic Metals is a peer-reviewed scientific journal published by Elsevier. It covers all aspects of electronic polymers and electronic molecular materials. It is an international medium for the rapid publication of original research papers, short communications and subject reviews dealing with research on and applications of electronic polymers and electronic molecular materials including novel carbon architectures. Original manuscripts on chemical, electrochemical, electrical, photonic...
